Navigation Links
North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
Date:8/2/2012

p capital investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.1 Table of Contents1 Table of Contents 21.1 List of Tables 71.2 List of Figures 112 Introduction 132.1 What is This Report About? 133 Cardiovascular Devices in North America 143.1 Cardiovascular Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 143.2 Cardiovascular Devices, North America, Overall Revenue ($m), USD Constant, 2004-2018 153.3 Cardiovascular Devices, North America, Company share (2010-2011) 234 Cardiovascular Devices In United States 254.1 Cardiovascular Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018 254.2 Cardiovascular Devices, United States, Distribution Share (2010-2011) 314.3 Cardiovascular Devices, United States, Company Share (2010-2011) 365 Cardiovascular Devices In Canada 555.1 Cardiovascular Devices, Canada, Overall Revenue ($m), USD Constant, 2004-2018 555.2 Cardiovascular Devices, Canada, Distribution Share (2010-2011) 615.3 Cardiovascular Devices, Canada, Company Share (2010-2011) 666 Overview of Key Companies in North America Cardiovascular Devices Market 886.1 Medtronic, Inc. 886.2 Boston Scientific Corporation 896.3 St. Jude Medical, Inc. 906.4 Abbott Laboratories 916.5 Cordis Corporation 926.6 C. R. Bard, Inc. 936.7 Thoratec Corporation 946.8 Sorin S.p.A. 946.9 Philips Healthcare 956.10 Covidien plc 956.11 MAQUET GmbH & Co. KG 966.12 Edwards Lifesciences Corporation 966.13 Terumo Corporation 976.14 Zoll Medical Corporation 976.15 Biosense Webster, Inc. 976.16 Biotronik SE & Co. KG 986.17 GE Healthcare 986.18 Volcano Corporation 986.19 Opto Circuits India Limited 996.20 AngioDynamics, Inc. 996.21 CareFusion Corporation 1006.22 Welch Allyn Inc. 1006.23 Schiller AG 1006.24 Teleflex Incorporated 1016.25 OSI Systems, Inc. 101
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
2. Northwest Bio Awarded $5.5 Million German Government Grant
3. Hill-Rom Appoints Alton Shader President of Hill-Rom North America
4. Instrumentation Laboratory Now Distributing Hemostasis Product Line In North America
5. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
6. North America ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
7. Analysis of the North American Radiology Image and Information Management Systems Market
8. North Dakotas Stop-Sale System Achieves Significant Results In Battle Against Meth
9. Somnetics Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence
10. American Academy of Family Physicians Foundation Launches Cities for Life
11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 The board of directors ... ) has declared a dividend for the third quarter ... stock. The dividend is payable September ... of business on August 15, 2013. Lilly, ... of pharmaceutical products by applying the latest research from ...
(Date:6/18/2013)... Today, Wall Street Reports announced new research reports ... Management Associates Inc. (NYSE: HMA ), IDEXX Laboratories, ... ISIS ), and Trius Therapeutics Inc. (NASDAQ: TSRX). ... including full price targets, industry analysis and analyst ratings - ... Report On June 7, 2013, Gilead Sciences Inc. ...
(Date:6/18/2013)... And EMERYVILLE, Calif. , ... presented final results today from a Phase 2/3 ... capsules demonstrating a statistically significant improvement in levodopa-induced ... at week 8 versus placebo in the Unified ... extended-release formulation of amantadine intended for once-nightly administration ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
... , April 29, 2010 Albireo today,announced ... recent study,assessing the safety, tolerability and efficacy of A3309 ... compound for,the treatment of irritable bowel syndrome with constipation ... during the 2010,Digestive Disease Week (DDW) annual meeting being ...
... SALT LAKE CITY , April 28 Sonic Innovations, ... Administration (VA), is conducting ongoing training events for government clinicians.  The company ... in San Diego, California and April 25 through ... for May 3 through 5 in Salt Lake City, ...
Cached Medicine Technology:Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 2Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 3Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 4Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 5Sonic Innovations Conducts National Training Events for Government Clinicians 2Sonic Innovations Conducts National Training Events for Government Clinicians 3
(Date:6/18/2013)... The world,s first computer guided fitness training system ... of the three winners of the LeWeb,13 London ... , The startup company, Genetrainer, building on ... PhD graduate, Ralph Pethica and Julian Gough, Professor ... Science, was selected from over 350 startups to ...
(Date:6/18/2013)... June 18, 2013 On June 12th, ... everything about medical marijuana in Canada . ... republish the new Canadian Marijuana for Medical Purposes Regulation ... department of Health Canada. , The Canabud.ca website is ... rapidly growing industry. “As medical marijuana becomes more ...
(Date:6/18/2013)... GA (PRWEB) June 18, 2013 Dr. ... of the Atlanta Vision Institute, is pleased to announce ... next generation of Intralase LASIK equipment, the iFS™ Advanced ... only LASIK practice in Atlanta to offer its patients ... Ashraf is giving his patients a complimentary upgrade to ...
(Date:6/18/2013)... 2013 The Skin and Vein Center ... public on July 9 from 2 p.m. to 5 p.m. ... with the doctor or a nurse, who will give the ... or nurse will inform the patient of the health of ... available for varicose and spider veins. , As part of ...
(Date:6/18/2013)... NY (PRWEB) June 18, 2013 Visitors to New ... a spa promotion from the famed JW Marriott Essex House ... New York City for business or pleasure, guests can take a ... rejuvenating day surrounded by serenity at The Spa at Essex House. ... at the Central Park hotel starting at $379 per night plus ...
Breaking Medicine News(10 mins):Health News:Atlanta LASIK Surgeon Offers New LASIK Technology 2Health News:Kansas City Dermatologists at The Skin and Vein Center Offer Complimentary Vein Screening on July 9 2Health News:New Spa Deal From JW Marriott Essex House New York Will Delight, Relax Visitors 2Health News:New Spa Deal From JW Marriott Essex House New York Will Delight, Relax Visitors 3
... Johns Hopkins University School of Medicine have identified a ... novel autoantibody specificity that makes them potential candidates for ... September issue of Arthritis & Rheumatism , a ... Myopathy is a term used to describe muscle disease. ...
... Aug. 19 (HealthDay News)-- There were no smiles on the faces ... waiting on line for help from the Oregon Employment Department were ... lecture from a middle-aged woman, who leaned in close and whispered ... a lot of unhappy, stressed people here." At rows of ...
... the mainstream media has led many researchers to study ... have indicated that there is a link between exposure ... of sexual activity among teens. However, a study led ... Published this month in the online version of ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Aug. ... eggs has sickened more than 250 people and led to ... news reports. The outbreak, which apparently began in May, ... and Prevention said. On Aug. 13, the CDC said: ...
... School of Medicine in Baltimore have developed a novel ... treatment for ventricular tachycardia, a potentially life-threatening heart rhythm ... The new approach couples CT (computed tomography) images with ... the heart that produce arrhythmias. The results of a ...
... Center in Israel have determined that the use ... outcome for patients undergoing percutaneous coronary intervention (PCI), ... appear in the September issue of Catheterization ... Wiley-Blackwell on behalf of The Society for Cardiovascular ...
Cached Medicine News:Health News:Novel autoantibodies identified in patients with necrotizing myopathy 2Health News:Novel autoantibodies identified in patients with necrotizing myopathy 3Health News:Jobless and Stressed but Holding Out Hope 2Health News:For teens, early sex and media exposure not linked 2Health News:Nationwide Egg Recall Underway 2Health News:Innovative imaging system may boost speed and accuracy in treatment of heart rhythm disorder 2Health News:Innovative imaging system may boost speed and accuracy in treatment of heart rhythm disorder 3Health News:Innovative imaging system may boost speed and accuracy in treatment of heart rhythm disorder 4Health News:Drug-eluting stents confirmed safe, effective for long-term use 2
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
... take their eyes for granted. Like ... eyes need proper nutrition and care ... vision as you age. In fact, ... to maintaining and preserving eye health ...
... The herbal extracts, vitamins, minerals, ... increases circulation to ocular tissue, ... healthy function of the lens ... This formula is optimized to ...
Online Unity Interlaboratory QC Data Management...
Medicine Products: